Cytex Therapeutics, Inc.

Basic Information

2608 Erwin Road
Suite 19A
Durham, NC, 27705-4597

http://www.cytextherapeutics.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 783502466
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 4


  1. Unicondylar Resurfacing in an Ovine Osteoarthritis Disease Model

    Amount: $190,720.00

    DESCRIPTION provided by applicant The treatment of large cartilage lesions is a difficult clinical problem for which there are few good solutions Left untreated these lesions tend to degenerate ...

    STTR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. A crosslinked cartilage-derived matrix for cartilage tissue engineering

    Amount: $570,289.00

    DESCRIPTION provided by applicant The overall goal of the present study is to resurface a diseased femoral condyle in an ovine model of unicompartmental osteoarthritis OA For patients suffering ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  3. SBIR Phase I: A Biosynthetic Composite Implant for Joint Resurfacing

    Amount: $149,993.00

    This Small Business Innovation Research (SBIR) Phase I project purposes to develop a new treatment for osteoarthritis, a debilitating joint disease characterized by significant tissue degeneration wit ...

    SBIR Phase I 2013 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government